Lv4
620 积分 2025-11-02 加入
Immune cells as tumor drug delivery vehicles
4小时前
已完结
Theranostic silica nanoparticles for selective and simultaneous delivery of paclitaxel and coumarin to hypoxic tumors
4小时前
待确认
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
4小时前
已完结
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
5小时前
已完结
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
11天前
已完结
A Universal Tumor-Specific Promoter for Cancer Gene Therapy
11天前
已完结
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study
11天前
已完结
Mechanisms, Clinical Trials, and New Treatments for BCG-Unresponsive in Nonmuscle Invasive Bladder Cancer
13天前
已完结
Abstract 7932: FL115, a novel IL-15 superagonist rationally designed to minimize safety risks for cancer immunotherapy
14天前
已关闭
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies
14天前
已完结
皖公网安备34019202002308
